[Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
J Zhang, Jian Zheng, Weijun Fang
Abstract
J Zhang, Jian Zheng, Weijun Fang
Abstract
OBJECTIVE: To investigate the correlation between p53 gene mutation and protein expression and discuss the sensitivities of immunohistochemistry and PCR-SSCP in detecting p53 abnormalities in lung cancer. METHODS: Immunohistochemistry, PCR-SSCP, and PCR-sequencing were used. RESULTS: 22 of 30 patients showed p53 mutations by PCR-sequencing. Mutations of 8 patients (36%) located on exon 5, 2(9%) on exon 6, 7 (32%) on exon 7, and 5(23%) on exon 8, respectively. 14 patients (64%) showed missense mutations, and 4(18%) neutral mutations, 3(14%) frameshifts and 1(5%) splice site mutation. In all mutations, G:C-->T:A transversions accounted for 41%(9/22). p53 missense mutations were found in all 10 patients whose immunohistochemistry and PCR-SSCP were both positive. Nine of 10 patients whose PCR-SSCP was positive but immunohistochemistry negative had p53 mutations, including 4 patients with neutral mutations, 3 frameshift mutations, 1 missense mutation, and 1 splice site mutation. In 10 patients whose immunohistochemistry was positive but PCR-SSCP negative, only 3 showed p53 missense mutations. CONCLUSION: Most of p53 mutation sites located on exon 5 and exon 7 in lung cancer of China. Missense mutations and G to T transversions were prevalent. If both PCR-SSCP and immunohistochemistry gave the positive results, p53 missense mutations may be expected.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the correlation between p53 gene mutation and protein expression and discuss the sensitivities of immunohistochemistry and PCR-SSCP in detecting p53 abnormalities in lung cancer. METHODS: Immunohistochemistry, PCR-SSCP, and PCR-sequencing were used. RESULTS: 22 of 30 patients showed p53 mutations by PCR-sequencing. Mutations of 8 patients (36%) located on exon 5, 2(9%) on exon 6, 7 (32%) on exon 7, and 5(23%) on exon 8, respectively. 14 patients (64%) showed missense mutations, and 4(18%) neutral mutations, 3(14%) frameshifts and 1(5%) splice site mutation. In all mutations, G:C-->T:A transversions accounted for 41%(9/22). p53 missense mutations were found in all 10 patients whose immunohistochemistry and PCR-SSCP were both positive. Nine of 10 patients whose PCR-SSCP was positive but immunohistochemistry negative had p53 mutations, including 4 patients with neutral mutations, 3 frameshift mutations, 1 missense mutation, and 1 splice site mutation. In 10 patients whose immunohistochemistry was positive but PCR-SSCP negative, only 3 showed p53 missense mutations. CONCLUSION: Most of p53 mutation sites located on exon 5 and exon 7 in lung cancer of China. Missense mutations and G to T transversions were prevalent. If both PCR-SSCP and immunohistochemistry gave the positive results, p53 missense mutations may be expected.
Key concepts: Missense mutation, Exon, Frameshift mutation, Molecular biology, Single-strand conformation polymorphism, Biology, Mutation, Immunohistochemistry